White Paper

Strategies for Accelerating the Development of Modified Release Oral Forms

Global expertise, local partner.

An innovative drug development and manufacturing organization, right on your doorstep.

Access the global expertise of an innovative drug development and manufacturing organization, right on your doorstep.

Did you know that Quotient Sciences is a leading formulation and manufacturing partner for pharma and biotech organisations, with facilities located in the UK and US?

We support clients at different stages of development:

  • Candidate selection to preclinical
  • First-in-Human to Proof-of-Concept
  • Proof-of-Concept to commercial product

Our UK footprint includes sites in Reading, Nottingham and Edinburgh, with a broad spectrum of capabilities and expertise, making us your perfect local partner.

Spotlight on our Reading site

  • A purpose built 48,000 ft² facility
  • Our facility has recently expanded from three to 12 GMP manufacturing suites.
  • We can support traditional Phase I-III clinical trial manufacturing and Translational Pharmaceutics® programs that integrate real-time adaptive manufacturing and clinical testing. 
  • We routinely scale-up products for Phase II supply
  • Our site has 20-years’ experience in supporting the development of small molecule drug products for oral and inhaled delivery. 
  • Salt & polymorph screening and pre-formulation
  • Modified release expertise
  • Experienced in inhaled dosage forms (DPI, pMDI), solid & liquid oral dosage forms
  • We’ve expanded employee numbers by 40% in the last 2 years

Take a look at our 'Spotlight on Reading' blog post to find out more about our Reading facility and the team that work there. 

Connect with your perfect local partner and ensure:

  • A closer partnership through more frequent face-to-face meetings
  • Easier monitoring of your program
  • Rapid reaction to technical challenges and problem solving
  • Lower audit costs
  • Avoidance of unpredictable exchange rate fluctuations
  • Benefit from local knowledge from global experts
  • Access to a strong understanding of MHRA, EMA, regulatory requirements

Meet Chris Landeg, Site Head of Quotient Sciences' facility in Reading

Chris oversees all formulation development and clinical trial manufacturing projects that are conducted in Reading.

He has spent almost his entire career working in contract pharmaceutical services businesses.

From his work in the laboratory in his early career, through to various commercial, project and operations roles, He now heads Quotient Sciences’ operations in Reading.

Learn more, read our full Q&A with Chris Landeg

Get in touch with Quotient

What do our customers say?

Learn more with our case study from Druggability Technologies 

Discover how we can routinely take drug products from pre-clinical to Phase I to commercial supply.

“Quotient has reduced our time-to-clinic and time-to-market. They understand the issues in drug development and have taken us from early stage to commercial in the most efficient way”

Gábor Heltovics, CEO, Druggability Technologies

Where can I meet Quotient Sciences?

Upcoming conferences and seminars

CPhI Worldwide

Frankfurt, Germany - November 5th - 7th
Discuss your drug development needs 
Schedule a meeting at our booth #121C52 

AAPS PharmSci 360

San Antonio, TX, US, November 3rd - 6th 
Discuss your drug development needs 
Schedule a meeting at our booth #627

Get in touch today

Would you like to receive further scientific content including case studies, whitepapers and seminar and webinar invitations?
You can find out how we handle your personal information in our privacy policy here.

Ready to get started?

Share Your Project Needs With Us

Ask us a question

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.